4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Controlled and tuneable drug release from electrospun fibers and a non-invasive approach for cytotoxicity testing

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Electrospinning is an attractive method to generate drug releasing systems. In this work, we encapsulated the cell death-inducing drug Diclofenac (DCF) in an electrospun poly-L-lactide (PLA) scaffold. The scaffold offers a system for a sustained and controlled delivery of the cytotoxic DCF over time making it clinically favourable by achieving a prolonged therapeutic effect. We exposed human dermal fibroblasts (HDFs) to the drug-eluting scaffold and employed multiphoton microscopy and fluorescence lifetime imaging microscopy. These methods were suitable for non-invasive and marker-independent assessment of the cytotoxic effects. Released DCF induced changes in cell morphology and glycolytic activity. Furthermore, we showed that drug release can be influenced by adding dimethyl sulfoxide as a co-solvent for electrospinning. Interestingly, without affecting the drug diffusion mechanism, the resulting PLA scaffolds showed altered fibre morphology and enhanced initial DCF burst release. The here described model could represent an interesting way to control the diffusion of encapsulated bio-active molecules and test them using a marker-independent, non-invasive approach.

          Related collections

          Most cited references74

          • Record: found
          • Abstract: found
          • Article: not found

          Penetration enhancers.

          One long-standing approach for improving transdermal drug delivery uses penetration enhancers (also called sorption promoters or accelerants) which penetrate into skin to reversibly decrease the barrier resistance. Numerous compounds have been evaluated for penetration enhancing activity, including sulphoxides (such as dimethylsulphoxide, DMSO), Azones (e.g. laurocapram), pyrrolidones (for example 2-pyrrolidone, 2P), alcohols and alkanols (ethanol, or decanol), glycols (for example propylene glycol, PG, a common excipient in topically applied dosage forms), surfactants (also common in dosage forms) and terpenes. Many potential sites and modes of action have been identified for skin penetration enhancers; the intercellular lipid matrix in which the accelerants may disrupt the packing motif, the intracellular keratin domains or through increasing drug partitioning into the tissue by acting as a solvent for the permeant within the membrane. Further potential mechanisms of action, for example with the enhancers acting on desmosomal connections between corneocytes or altering metabolic activity within the skin, or exerting an influence on the thermodynamic activity/solubility of the drug in its vehicle are also feasible, and are also considered in this review.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A simple equation for the description of solute release. III. Coupling of diffusion and relaxation

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Biodegradable electrospun fibers for drug delivery.

              The influences of surfactants and medical drugs on the diameter size and uniformity of electrospun poly(L-lactic acid) (PLLA) fibers were examined by adding various surfactants (cationic, anionic, and nonionic) and typical drugs into the PLLA solution. Significant diameter reduction and uniformity improvement were observed. It was shown that the drugs were capsulated inside of the fibers and the drug release in the presence of proteinase K followed nearly zero-order kinetics due to the degradation of the PLLA fibers. Such ultrafine fiber mats containing drugs may find clinical applications in the future.
                Bookmark

                Author and article information

                Contributors
                svenja.hinderer@nmi.de
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                5 March 2019
                5 March 2019
                2019
                : 9
                : 3446
                Affiliations
                [1 ]ISNI 0000000119391302, GRID grid.7367.5, Department of Science, , University of Basilicata, ; 85100 Potenza, Italy
                [2 ]ISNI 0000 0001 2190 1447, GRID grid.10392.39, Department of Women’s Health, Research Institute for Women’s Health, , Eberhard-Karls-University Tübingen, ; 72076 Tübingen, Germany
                [3 ]ISNI 0000 0000 9457 1306, GRID grid.461765.7, Department of Biophysical Chemistry, , Natural and Medical Sciences Institute (NMI) at the University of Tübingen, ; 72770 Reutlingen, Germany
                [4 ]ISNI 0000 0000 9632 6718, GRID grid.19006.3e, Department of Medicine/Cardiology, , Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, ; Los Angeles, CA USA
                Author information
                http://orcid.org/0000-0001-8214-3811
                Article
                40079
                10.1038/s41598-019-40079-7
                6401126
                178cebe8-1028-4eb6-8c4f-8171d572caf1
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 October 2018
                : 8 February 2019
                Funding
                Funded by: DAAD 57130104
                Funded by: FundRef https://doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft (German Research Foundation);
                Award ID: SCHE701/14-1, INST 2388/30-1
                Award Recipient :
                Funded by: Minitry of Research, Science and Arts of Baden-Württemberg SI-BW 01222-91, 33-729.55-3/214
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                Uncategorized

                Comments

                Comment on this article